Literature DB >> 10670828

Differential effects of hemorrhage and LPS on tissue TNF-alpha, IL-1 and associate neuro-hormonal and opioid alterations.

P E Molina1, N N Abumrad.   

Abstract

LPS administration and hemorrhage are frequently used models for the in vivo study of the stress response. Both challenges stimulate cytokine production as well as activate opiate and neuro-endocrine pathways; which in turn modulate the inflammatory process. Differences in the magnitude and tissue specificity of the proinflammatory cytokine and neuro-hormonal responses to these stressors are not well established. We contrasted the tissue specificity and magnitude of the increase in circulating and tissue cytokine (TNF-alpha, IL-1alpha and IL-1beta) content in response to either fixed-pressure hemorrhage (approximately 40 mm Hg) followed by fluid resuscitation (HEM) or lipopolysaccharide (LPS; 100 microg/100 g BW) administration. LPS and HEM elevated circulating levels of TNF-alpha, while neither stress altered circulating IL-1-alpha and IL-beta. LPS-induced increases in TNF-alpha content were greater than those elicited by HEM in all tissues studied except for the lung, where both stressors produced similar increases. Tissue (lung, spleen and heart) content of IL-1alpha was increased by HEM but was not affected by LPS. Tissue (lung, spleen, and heart) content of IL-1beta was increased by LPS but was not affected by HEM. HEM produced greater increases than LPS in epinephrine (16- vs. 4-fold) and norepinephrine (4-fold vs. 60%) levels and similar elevations in beta-endorphin. LPS produced greater elevation in corticosterone levels (2-fold) than HEM (50%). These results suggest differential tissue cytokine modulation to HEM and LPS, both with respect to target tissue and cytokine type. The hormonal milieu to HEM is characterized by marked catecholaminergic and moderate glucocorticoid while that of LPS is characterized by marked glucocorticoid with moderate catecholaminergic influence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670828     DOI: 10.1016/s0024-3205(99)00606-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury.

Authors:  Sophie X Teng; Patricia E Molina
Journal:  J Neurotrauma       Date:  2013-12-20       Impact factor: 5.269

2.  Effect of cholecystokinin on cytokines during endotoxic shock in rats.

Authors:  Y L Ling; A H Meng; X Y Zhao; B E Shan; J L Zhang; X P Zhang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Sympathetic modulation of the host defense response to infectious challenge during recovery from hemorrhage.

Authors:  Annie M Whitaker; Jesse Sulzer; Edith Walker; Keisa Mathis; Patricia E Molina
Journal:  Neuroimmunomodulation       Date:  2010-05-27       Impact factor: 2.492

4.  CCK-8 inhibits expression of TNF-alpha in the spleen of endotoxic shock rats and signal transduction mechanism of p38 MAPK.

Authors:  Ai-Hong Meng; Yi-Ling Ling; Xiao-Peng Zhang; Xiao-Yun Zhao; Jun-Lan Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

5.  Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat.

Authors:  Ai-Hong Meng; Yi-Ling Ling; Xiao-Peng Zhang; Jun-Lan Zhang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Heme oxygenase-1 in cholecystokinin-octapeptipe attenuated injury of pulmonary artery smooth muscle cells induced by lipopolysaccharide and its signal transduction mechanism.

Authors:  Xin-Li Huang; Yi-Ling Ling; Yi-Qun Ling; Jun-Lin Zhou; Yan Liu; Qiu-Hong Wang
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 7.  Contribution of α - and β -Adrenergic Mechanisms to the Development of Pulmonary Edema.

Authors:  Beate Rassler
Journal:  Scientifica (Cairo)       Date:  2012-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.